AgeDefy Peptide: NAD+ and MOTS-c research FAQ
The questions become more useful when they name the ingredient, the kind of result and the people or animals actually studied.
What is NAD supplement used for?
Oral precursors such as NMN and NR are studied to raise NAD+ availability. Human trials have demonstrated blood NAD+ elevation with NR and with NMN; one trial in prediabetic, postmenopausal women found improved muscle insulin sensitivity. The 2025 review describes limited clinical efficacy and sparse tissue-specific data. Human longevity or disease-prevention benefits remain unproven.
What is the downside of taking NAD+?
The answer depends on the preparation and route. The current account describes poor intact uptake of oral NAD+, limited controlled evidence for infusions, infusion-related chest or abdominal discomfort, flushing and nausea, and contamination risks. FDA recalled a compounded NAD+ injection for elevated bacterial endotoxin (Class I). There is a theoretical concern about supporting existing cancers because NAD+ also supports proliferating cells; its role in cell biology makes that question context-dependent. Oral precursor trial findings give only a limited period of safety observation.
Is it safe to take NAD daily?
The trial durations leave me unable to judge long-term daily use. In the 60-day NMN trial, no safety concerns were reported at the studied doses. In the 8-week NR trial, adverse-event differences from placebo were not significant. These were selected participants and finite study periods. Long-term safety across diverse people and the safety of other preparations remain separate questions.
Do NAD+ trials report weight gain?
The NMN trial in prediabetic, postmenopausal women improved muscle insulin sensitivity without changing body composition or HbA1c. That is the more useful specific result to take from this record. It establishes neither weight gain nor a weight-loss benefit for every NAD+ preparation. I lose confidence when an insulin-sensitivity result quietly becomes a weight-change claim.
Which MOTS-c effects have been measured?
MOTS-c is a 16-amino-acid peptide encoded in mitochondrial DNA. Cell and animal work describes folate-cycle effects, AMPK activation and stress signaling. The CK2 investigation connected direct binding in cell-free assays with muscle glucose uptake and atrophy findings in mice. Another study reported better running capacity, grip strength and gait in aged mice. The human efficacy of administered MOTS-c remains unestablished.
How much is known about MOTS-c side effects?
Completed human clinical trials have not established a reliable side-effect profile, half-life or dose-response for administered MOTS-c in this record. The review of MOTS-c biology provides the broader research context, while the MOTS-c page covers the genetic-variation, replication and supply-quality concerns. A naturally occurring peptide can still require extensive safety work when administered as an intervention.
What is MOTS-c’s regulatory status?
MOTS-c has no FDA approval, including as a compounded medication. Laboratory-labelled supply remains distinct from patient-specific prescription preparations following clinical assessment. Research supply is not regulated as a pharmaceutical for identity, purity or sterility. MOTS-c is also prohibited in governed sport under hormone and metabolic-modulator anti-doping categories; use can lead to sanctions.
How often do you inject MOTS-c?
There is no validated human administration schedule established by the completed clinical trials in this record. The physical-capacity experiments were in mice, and the dialysis cohort measured naturally circulating MOTS-c without assigning peptide treatment. Neither supplies a human injection plan. This site offers no dosing or injection instructions.
How do NAD+ and MOTS-c relate to muscle?
They reach the muscle question by different routes. NAD+ participates in energy metabolism; an oral NMN trial tested insulin sensitivity in human muscle. MOTS-c research includes CK2, muscle glucose uptake and atrophy experiments in mice. Muscle function is the common territory that interests me, while the comparison spells out why that shared territory supplies no direct contest or proven combination benefit.